This comes just under a month after Pfizer finalised a deal to acquire Metsera following a bidding war with Novo Nordisk.

The Alabama facility is part of the $27bn investment Eli Lilly has pledged to expand its US footprint. American ...

A new review of nearly 100,000 participants suggests that glucagon-like peptide-1 receptor agonists (GLP-1RAs), popular ...

A major moment in India’s fight against type-2 diabetes arrived this week with the launch of Ozempic, the globally popular semaglutide drug known for its strong effects on blood sugar control and ...

Leerink analyst David Risinger notes that Pfizer (PFE) disclosed on December 9, 2025, that it entered into an exclusive global collaboration and ...

Eli Lilly’s triple glucagon agonist has achieved up to 28.7% weight loss in a Phase III trial.

Discover why Terns Pharmaceuticals, Inc. stock is up 770% YTD with strong CML drug data and major upcoming milestones. Click ...

Discover why Structure Therapeutics Inc. is rated Strong Buy after positive Aleniglipron phase 2b obesity data. Click for ...

London, UK – 9th December 2025. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on ...

Pharma's post-Covid growth faces challenges as margin compression and strategic shifts emerge in 2026, urging a bottom-up ...

In this systematic review and meta-analysis, use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) was not associated ...

Thyssenkrupp is entangled in a restructuring process as it seeks to shore up its finances, hit by high energy costs and cheap ...